Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes.
Goto S, Fujii H, Kono K, Nakai K, Hamada Y, Yamato H, Shinohara M, Kitazawa R, Kitazawa S, Nishi S, Fukagawa M.
Goto S, et al. Among authors: nakai k.
Am J Nephrol. 2011;34(3):281-90. doi: 10.1159/000330853. Epub 2011 Aug 9.
Am J Nephrol. 2011.
PMID: 21829007